Monique Malléa
Centre national de la recherche scientifique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Monique Malléa.
Microbiology | 1998
Monique Malléa; Jacqueline Chevalier; Charléric Bornet; Annie Eyraud; Anne Davin-Regli; Claude Bollet; Jean-Marie Pagès
Enterobacter aerogenes is among the five most frequently isolated nosocomial pathogens in France, and this bacterium also shows increasing multidrug resistance. In this study, various E. aerogenes strains isolated from hospital units were characterized for their outer-membrane proteins, antibiotic susceptibilities (inhibition diameters and MICs) and resistance mechanisms associated with modification of envelope permeability (porin alteration and active efflux). Diminished outer-membrane permeability due to porin alterations was found in conjunction with the expression of an enzymic barrier in resistant isolates. Interestingly, changes in the functional expression of porins appeared to play a special role in susceptibility to cefepime. An active efflux to quinolones was also identified. Simultaneous changes in envelope permeability, i.e. a porin deficiency (in) and an efflux mechanism (out), were clearly evident in two clinical strains.
Antimicrobial Agents and Chemotherapy | 2004
Jacqueline Chevalier; Jérôme Bredin; Abdallah Mahamoud; Monique Malléa; Jacques Barbe; Jean-Marie Pagès
ABSTRACT In Enterobacter aerogenes and Klebsiella pneumoniae, efflux provides efficient extrusion of antibiotics and contributes to the multidrug resistance phenotype. One of the alkoxyquinoline derivatives studied here, 2,8-dimethyl-4-(2′-pyrrolidinoethyl)-oxyquinoline, restores noticeable drug susceptibility to resistant clinical strains. Analyses of energy-dependent chloramphenicol efflux indicate that this compound inhibits the efflux pump mechanism and improves the activity of structurally unrelated antibiotics on multidrug-resistant E. aerogenes and K. pneumoniae isolates.
Biochemical and Biophysical Research Communications | 2003
Charléric Bornet; Renaud Chollet; Monique Malléa; Jacqueline Chevalier; Anne Davin-Regli; Jean-Marie Pagès; Claude Bollet
Imipenem is often used to treat intensive care unit patients infected by Enterobacter aerogenes, but it is leading to an increasing number of antibiotic resistant strains. Clinical isolates and imipenem resistant variants presented a high level of resistance to beta-lactam antibiotic group and to chemically unrelated drugs. We report here that imipenem selects strains which contain active efflux pumps ejecting various unrelated antibiotics including quinolones, tetracycline, and chloramphenicol. An increase of AcrA, an efflux pump component, was observed in the imipenem resistant variants. The overexpression of marA, involved in the genetic control of membrane permeability via porin and efflux pump expression, indicated the activation of the resistance genetic cascade in imipenem resistant variants.
Biochemical and Biophysical Research Communications | 2002
Monique Malléa; Jacqueline Chevalier; Annie Eyraud; Jean-Marie Pagès
Enterobacter aerogenes, a nosocomial pathogen, is frequently exhibiting multidrug resistance mechanisms associated with a change in membrane permeability. In clinical isolates, active efflux plays a prominent role in antibiotic resistance. We report here the effect of three unrelated compounds that are able to restore a noticeable antibiotic susceptibility to resistant strains. The targeting of various parameters which contribute to the efficacy of the efflux mechanism, such as energy, flux selectivity, or functional assembly of the membrane complex, increases the intracellular chloramphenicol concentration in resistant isolates.
Antimicrobial Agents and Chemotherapy | 2000
Valérie Simonet; Monique Malléa; Jean-Marie Pagès
ABSTRACT The Escherichia coli OmpF porin is a nonspecific channel involved in the membrane translocation of small hydrophilic molecules and especially in the passage of β-lactam antibiotics. In order to understand the dynamic of charged-compound uptake through bacterial porins, specific charges located in the E. coliOmpF channel were mutated. Substitutions G119D and G119E, inserting a protruding acidic side chain into the pore, decreased cephalosporin and colicin susceptibilities. Cefepime diffusion was drastically altered by these mutations. Conversely, substitutions R132A and R132D, changing a residue located in the positively charged cluster, increased the rate of cephalosporin uptake without modifying colicin sensitivity. Modelling approaches suggest that G119E generates a transverse hydrogen bond dividing the pore, while the two R132 substitutions stretch the channel size. These charge alterations located in the constriction area have differential effects on cephalosporin diffusion and substantially modify the profile of antibiotic susceptibility.
Antimicrobial Agents and Chemotherapy | 2002
Renaud Chollet; Claude Bollet; Jacqueline Chevalier; Monique Malléa; Jean-Marie Pagès; Anne Davin-Regli
ABSTRACT We determined the sequence of the entire marRAB operon in Enterobacter aerogenes. It is functionally and structurally analogous to the Escherichia coli operon. The overexpression of E. aerogenes MarA induces a multidrug resistance phenotype in a susceptible strain, demonstrated by a noticeable resistance to various antibiotics, a decrease in immunodetected porins, and active efflux of norfloxacin.
Natural Product Letters | 1993
Ahmed Melhaoui; Monique Malléa; Akino Jossang; Bernard Bodo
Abstract A new pyrrolidine alkaloid, bgugaine, 1 was isolated along with irniine, 2, from Arisarum vulgare tubers and its structure elucidated by 1H and 13C 2D-COSY NMR techniques. The antibiotic and antifungal properties of both alkaloids were investigated. They exhibited inhibitory effects on the growth of Gram-positive bacteria, yeasts and some filamentous fungi.
Fems Microbiology Letters | 1995
Monique Malléa; Valérie Simonet; Eun-Hee Lee; R Gervier; Ekkehard Collatz; L Gutmann; Jean-Marie Pages
Bacteriocin susceptibilities indicate that during cloacin DF13 uptake the F porin of Enterobacter cloacae plays a similar role to that reported for the OmpF porin of Escherichia coli during colicin A entry. The translocatory activities of these two porins during the bacteriocin uptake can be substituted by the porins D and OmpC, respectively, under conditions not requiring the receptor binding step. Using anti-peptide antibodies, a peptide located in the internal loop L3 of the Escherichia coli OmpF porin was identified in the D and F porins of Enterobacter cloacae. The results demonstrated the existence of a close relationship between porins in terms of both antigenic determinants and bacteriocin susceptibilities.
Journal of Clinical Microbiology | 1999
Claude Bosi; Anne Davin-Regli; Charléric Bornet; Monique Malléa; Jean-Marie Pagès; Claude Bollet
Biochemical Journal | 2003
Monique Malléa; Abdallah Mahamoud; Jacqueline Chevalier; Sandrine Alibert-Franco; Pierre Brouant; Jacques Barbe; Jean-Marie Pagès